Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biogena Group Invest AGWBO:BIO +1.90%60 Return-on-Tangible-Equity is 3.35% as of Jan. 2026, which is 4% below its 10-year median of 3.48. GuruFocus rates WBO:BIO with a GF Score™ of 60/100 and a GF Value™ of €3.48 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,880 Consumer Packaged Goods companies, Biogena Group Invest AG ranks worse than 66.54% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Biogena Group Invest AG's annualized net income for the quarter that ended in Jan. 2026 was €0.29 Mil. Biogena Group Invest AG's average shareholder tangible equity for the quarter that ended in Jan. 2026 was €8.75 Mil. Therefore, Biogena Group Invest AG's annualized Return-on-Tangible-Equity for the quarter that ended in Jan. 2026 was 3.35%.
The historical rank and industry rank for Biogena Group Invest AG's Return-on-Tangible-Equity or its related term are showing as below:
WBO:BIO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -27.66 Med: 3.48 Max: 13.61
Current: 3.35
During the past 7 years, Biogena Group Invest AG's highest Return-on-Tangible-Equity was 13.61%. The lowest was -27.66%. And the median was 3.48%.
WBO:BIO's Return-on-Tangible-Equity is ranked worse than 66.54% of 1880
companies
in the Consumer Packaged Goods industry
Industry Median: 7.845
vs WBO:BIO: 3.35
Biogena Group Invest AG (WBO:BIO) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Biogena Group Invest AG Return-on-Tangible-Equity Related Terms
Biogena Group Invest AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Biogena Group Invest AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogena Group Invest AG Return-on-Tangible-Equity Chart
WBO:BIO vs KHC, GIS, HRL: Return-on-Tangible-Equity Comparison
For the Packaged Foods subindustry, Biogena Group Invest AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogena Group Invest AG Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Biogena Group Invest AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Jan. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 3.35% mean?
Biogena Group Invest AG (WBO:BIO) has a Return-on-Tangible-Equity of 3.35% as of Jan. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Biogena Group Invest AG and its competitors. This is near median its historical median of 3.48. According to the industry distribution chart, Biogena Group Invest AG ranks #1251 out of 1880 companies in the Consumer Packaged Goods industry, placing it in the top 66.5%.
Is Biogena Group Invest AG's Return-on-Tangible-Equity too high?
Biogena Group Invest AG's current Return-on-Tangible-Equity of 3.35% is near median its 10-year median of 3.48. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.85. Biogena Group Invest AG's value of 3.35% is 57.3% below this industry median. Based on the distribution chart, Biogena Group Invest AG ranks #1251 out of 1880 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Biogena Group Invest AG has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Return-on-Tangible-Equity compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biogena Group Invest AG ranks #1251 out of 1880 companies for Return-on-Tangible-Equity. This places Biogena Group Invest AG in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.85. Biogena Group Invest AG's value of 3.35% is 57.3% below this benchmark. While the company's 10-year median is 3.48 vs. the industry median of 7.85, Biogena Group Invest AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.85, based on 1,880 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biogena Group Invest AG's current Return-on-Tangible-Equity of 3.35% is 57.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Biogena Group Invest AG and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biogena Group Invest AG's current Return-on-Tangible-Equity is 3.35%, which is near median its own 10-year median of 3.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.48, compared to a current price of €5.35 — trading 53.7% above its estimated fair value. The current Return-on-Tangible-Equity is 3.35%, which is near median its 10-year median of 3.48 and 57.3% below the Consumer Packaged Goods industry median of 7.85. Biogena Group Invest AG's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Return-on-Tangible-Equity is 3.35% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued.
The current stock price of €5.35 is trading 53.7% above its estimated GF Value™ of €3.48.
GuruFocus considers Biogena Group Invest AG to be Significantly Overvalued.
Key valuation signals for WBO:BIO:
Return-on-Tangible-Equity: 3.35% (near median its 10-year median of 3.48)
GF Value™: €3.48 vs. price of €5.35 (53.7% above fair value)
Industry Position: 57.3% below the Consumer Packaged Goods median (#1251 of 1880)
No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
60GF Score
Get the complete analysis for WBO:BIO
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BIO has been successfully added to your 
